Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Phase 3 clinical trials are under way (see ClinicalTrials.gov for current registered studies), and whilst early Phase 2 results are encouraging, retatrutide is not legally available as a prescribed medicine in the UK outside of approved clinical trial settings
Most clinical and research GHK-Cu protocols sit at 0.52 mg per day subcutaneously, and many patients do not inject every day - 23 injections per week is common for skin and maintenance goals
They can evaluate individual health status, possible drug interactions, and suitability for therapy
That's why we make this simple: Quick in-office injections administered by our nurses Clear treatment plan with no guesswork Professional support whenever you have questions Flexible scheduling that works with your life You don't have to become an expert in peptide therapy
This is why the conversation about how long retatrutide lasts extends far beyond pharmacokinetics into questions about long-term treatment strategy
Maintaining a balanced diet and a healthy lifestyle can help support long-term results
